VANCOUVER, BC, Oct. 29, 2020 /CNW/ - ELSE NUTRITION HOLDINGS
INC. (TSX-V: BABY) (OTCQX: BABYF) (FSE: 0YL)
("Else" or the "Company"), a commercial stage
developer of plant-based alternatives to dairy-based baby
nutrition, is pleased to provide an update on its North
American product launch of its plant-based Toddler Nutrition
product.
Else has successfully completed a second commercial
manufacturing run, 300% larger than the initial production run, and
will commence a third manufacturing run in early November. This
planned production run is expected to be 200% larger than the
second run, and 600% larger than the inaugural one. Successful
scale-up of production while maintaining a consistent and
high-quality product is a major inflection point in the Company's
go-to market strategy. As a result, Else will generate
additional inventory to service the Company's expansion in the U.S.
market as it rapidly expands into retail distribution, and scales
its online sales.
"We are encouraged by the early response to our long awaited
product launch, and equally pleased to have to ramp up our
inventory as we continue to see strong demand for our novel,
clean-label, plant-based Toddler Nutrition product," said Mrs.
Hamutal Yitzhak, CEO and Co-Founder
of Else. "We are grateful for the very positive daily
feedback from parents across North
America, and look forward to bringing the product to store
shelves soon. Additionally, a consistent, high quality and
scalable manufacturing process is a critical pillar of our business
– we are pleased to have successfully completed two commercial
scale runs and look forward to exponentially scaling the next
one.
Else has completed the setup and order automation processes by
signing up with a third-party logistics company. This provider has
warehouses across the U.S. and Canada which will support Else's E-commerce
sales. Online order shipments have already commenced.
Else Nutrition's Plant-Based Complete Nutrition for Toddlers
& Babies (12+ mo.) is now available for sale on Else's e-store
at elsenutrition.com, and on Amazon.com. The Company also recently
added subscription plans on its e-store.
About Else Nutrition Holdings Inc.
Else Nutrition GH Ltd. is an Israel-based food and nutrition company
focused on developing innovative, clean and plant-based food and
nutrition products for infants, toddlers, children, and adults. Its
revolutionary, plant-based, non-soy, formula is a clean-ingredient
alternative to dairy-based formula. Else Nutrition (formerly INDI)
won the "2017 Best Health and Diet Solutions" award at the Global
Food Innovation Summit in Milan.
The holding company, Else Nutrition Holdings Inc., is a publicly
traded company, listed as TSX Venture Exchange under the trading
symbol BABY and is quoted on the US OTC Markets QX board under the
trading symbol BABYF and on the Frankfurt Exchange under the symbol
0YL. Else's Executives includes leaders hailing
from leading infant nutrition companies. Many of Else advisory
board members had past executive roles in companies such as
Mead Johnson, Abbott Nutrition, Plum Organics and leading infant
nutrition Societies, and some of them currently serve in
different roles in leading medical centers and academic institutes
such as Boston Children's Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv
University, Schneider Children's Medical Center of
Israel, Rambam Medical Center and
Technion, Israel and University
Hospital Brussels, Belgium.
For more information, visit: elsenutrition.com or
@elsenutrition on Facebook and Instagram.
TSX Venture Exchange
Neither the TSX Venture Exchange nor its regulation services
provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Caution Regarding Forward-Looking Statements
This press release contains statements that may constitute
"forward-looking statements" within the meaning of applicable
securities legislation. Forward-looking statements are typically
identified by words such as "will" or similar expressions.
Forward-looking statements in this press release include statements
with respect to the anticipated dates for filing the Company's
financial disclosure documents. Such forward-looking
statements reflect current estimates, beliefs and assumptions,
which are based on management's perception of current conditions
and expected future developments, as well as other factors
management believes are appropriate in the circumstances. No
assurance can be given that the foregoing will prove to be correct.
Forward-looking statements made in this press release assume, among
others, the expectation that there will be no interruptions or
supply chain failures as a result of COVID 19 and that the
manufacturing, broker and supply logistic agreement with the
Company do not terminate. Actual results may differ from the
estimates, beliefs and assumptions expressed or implied in the
forward-looking statements. Readers are cautioned not to
place undue reliance on any forward-looking statements, which
reflect management's expectations only as of the date of this press
release. The Company disclaims any obligation to update or revise
any forward-looking statements, whether as a result of new
information, future events or otherwise, except as required by
law.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/else-nutrition-announces-successful-completion-of-second-full-scale-manufacturing-run-and-commencement-of-third-full-scale-run-in-early-november-301162316.html
SOURCE Else Nutrition Holdings Inc.